21 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... #Management # ... Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing ... #Table #PAMI
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
and sodium • Dosing ... 10 g QD (adjust dose ... g QD; increase dose ... #medications #pharmacology ... #table #comparison
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... #Management # ... Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pearls for Treatment of Alcohol Use Disorder

First-line pharmacotherapies for moderate to severe AUD include naltrexone and
include abdominal pain ... respectively) at the doses ... #UseDisorder #Management ... Screening #Addiction #Medications ... #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... for renal dysfunction ... #pharmacology # ... comparison #table
Lyrica (Pregabalin) 
Indications: Neuropathy (diabetic, postherpetic neuralgia, fibromyalgia, & spinal cord injury), Adjunctive therapy for partial-onset
partial-onset seizures Dosing ... Adjust based on renal ... to be renally dose ... drug will likely cause ... Lyrica #Pregabalin #Pharmacology